Clinical Roundup Largest study on infant-type hemispheric glioma reports factors to guide treatment approaches November 21, 2025Vol.51 No.43
Clinical Roundup Targeted drug could benefit pediatric and young adult patients with invasive soft tissue cancer November 21, 2025Vol.51 No.43
Clinical Roundup Nuvalent announces positive topline pivotal data from ALKOVE-1 trial of neladalkib for TKI pre-treated patients with advanced ALK-positive NSCLC November 21, 2025Vol.51 No.43
Clinical Roundup UAMS study finds digital barriers may limit rural cancer survivors from participating in research November 14, 2025Vol.51 No.42
Clinical Roundup Xilio Therapeutics announces Phase II data for Vilastobart in MSS mCRC November 14, 2025Vol.51 No.42
Clinical Roundup Alliance launches trial to study exercise in cancer patients November 14, 2025Vol.51 No.42
Clinical Roundup Researchers discover gene that could help improve treatment decisions in childhood leukemia November 14, 2025Vol.51 No.42
Clinical Roundup Five genes linked to aggressive prostate cancer in men of African descent, USC study identifies November 07, 2025Vol.51 No.41
Clinical Roundup Some p53 mutations could help fight cancer, Baylor study finds November 07, 2025Vol.51 No.41
Clinical Roundup Ozekibart improves PFS in chondrosarcoma, registrational phase II trial shows October 31, 2025Vol.51 No.40
